European Journal Of Medicinal Chemistry

SCI SCIE

国际简称：EUR J MED CHEM 参考译名：欧洲药物化学杂志

主要研究方向：化学-医药化学非预警期刊审稿周期：约4.3个月

《欧洲药物化学杂志》(European Journal Of Medicinal Chemistry)是一本由Elsevier Masson SAS出版的以化学-医药化学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
1042 年发文量
6.7 IF影响因子
未开放 是否OA
135 H-index
1965 创刊年份
Monthly 出版周期
Multi-Language 出版语言

The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.

A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.

[ 查看全部 ]

投稿咨询加急咨询

European Journal Of Medicinal Chemistry期刊信息

ISSN：0223-5234
出版语言：Multi-Language
是否OA：未开放
E-ISSN：1768-3254
出版地区：FRANCE
是否预警：否
出版商：Elsevier Masson SAS
出版周期：Monthly
创刊时间：1965
开源占比：0.0439
Gold OA文章占比：15.37%
OA被引用占比：0.0169...
出版国人文章占比：0.29
出版撤稿占比：0.0011...
研究类文章占比：81.19%

European Journal Of Medicinal Chemistry CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

10.8

1.152

1.342

学科类别	分区	排名	百分位
大类：Chemistry 小类：Organic Chemistry	Q1	18 / 215	91%
大类：Chemistry 小类：Pharmacology	Q1	33 / 328	90%
大类：Chemistry 小类：Drug Discovery	Q1	24 / 161	85%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

European Journal Of Medicinal Chemistry中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	CHEMISTRY, MEDICINAL 药物化学	2区

European Journal Of Medicinal Chemistry JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CHEMISTRY, MEDICINAL	SCIE	Q1	11 / 72	85.4
学科：CHEMISTRY, MEDICINAL	SCIE	Q1	11 / 72	85.42

European Journal Of Medicinal Chemistry历年数据统计

影响因子

中科院分区

European Journal Of Medicinal Chemistry中国学者发文选摘

1、Design, synthesis, and anti-HPV activity evaluation of neocryptolepine derivatives with boronic acid modificatio
Author: Zhang, Kai; Li, Zhengjuan; Liu, Shan; Liu, Lu; Sunyang, Ziyi; Liu, Xiaochun; Zhao, Lili; Yin, Ruijuan; Jiang, Tao

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 312, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118850
2、Porphyrins modified fibroblast activation protein inhibitor for enhanced cancer radionuclide therap
Author: Wang, Yadong; Chen, Jiajun; Li, Xuanyang; Guo, Jingsi; Fan, Xisheng; Yang, Yuanyou; Liu, Ning; Liao, Jiali; Li, Feize

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 311, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118820
3、Rational design and synthesis of flavonolactam derivatives as potent topo I inhibitors with antitumor activit
Author: Shi, Xiaoyu; Huang, Yaoguang; Yang, Xupeng; Wang, Mingyu; Han, Xu; Yang, Shengnan; Li, Wenjing; Jia, Jingming; Wang, Anhua; Huang, Shaohui

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 311, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118804
4、Discovery of novel covalent agonists for p53 Y220C through synergistic strategy combining covalent binding and scaffold hoppin
Author: Li, Linquan; Meng, Jingyi; Xu, Fengqian; Wang, Kang; Wang, Xiaoqian; Gu, Xi; Shen, Haiwei; Zhang, Sulin; Zuo, Zhili

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 311, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118801
5、GalNAc-CPP conjugates improve the efficiency of oligonucleotide drugs in viv
Author: Lu, Lei; Cong, Dezi; Ma, Wei; Wang, Guoxia; Wang, Haisheng; Wang, Xiaolei

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 311, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118821
6、Iminocarbamoyl-hybridized nitrofuranylcoumarins as broad-spectrum antibacterial agents with multitargeting potentia
Author: Huang, Shi-Yu; Ahmad, Nisar; Yu, Jia-Chen; Cheng, Qian; Zhang, Shao-Lin; Zhou, Cheng-He

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 311, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118819
7、Design, synthesis, and biological evaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[4,3-c]pyridine derivatives targeting the colchicine-binding site as new tubulin inhibitor
Author: Guo, Zhu; Liu, Chang; Zhang, Yujing; Xu, Qianqian; Cui, Liya; Chen, Wujun; Wang, Chao

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 311, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118827
8、Novel design of interleukin-2 derivatives with reversed pH and potent antitumor activit
Author: Liu, Yu; Liu, Qiuyue; Zhao, Wenjie; Wang, Zhaofeng; Zhong, Guyu; Yi, Juntao; Zheng, Yuzhou; Hao, Xinlong; Peng, Dezheng; Tang, Dongfang; Zhang, Yunxiao

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026; Vol. 311, Issue , pp. -. DOI: 10.1016/j.ejmech.2026.118815